The Merck Access Program
The Merck Access Program may be able to:
•Identify your insurance benefits
• Obtain information about your out-of-pocket costs
• Provide information on co-pay assistance options for eligible patients
• Refer you to the Merck Patient Assistance Program for an eligibility determination
(provided by the Merck Patient Assistance Program, Inc.)
Questions?
Contact the Merck Access Program at 855-404-5278 Mon-Fri, 8 AM to 8 PM (ET), to speak to a representative.
What is VERQUVO?
VERQUVO is a prescription medicine used in adults who are having symptoms of
VERQUVO is a prescription medicine used in adults who are having symptoms of their chronic (long-lasting) heart failure, who have had a recent hospitalization or the need to receive intravenous (IV) medicines and have an ejection fraction (amount of blood pumped with each heartbeat) of less than 45 percent to reduce the risk of dying and to reduce the need to be hospitalized.
IMPORTANT SAFETY INFORMATION
VERQUVO may cause birth defects if taken during pregnancy.
- Females must not be pregnant when they start taking VERQUVO.
- For females who are able to get pregnant:
- Your healthcare provider will do a pregnancy test to make sure that you are not pregnant before you start taking VERQUVO.
VERQUVO may cause birth defects if taken during pregnancy.
- Females must not be pregnant when they start taking VERQUVO.
VERQUVO is a prescription medicine used in adults who are having symptoms of their chronic (long-lasting) heart failure, who have had a recent hospitalization or the need to receive intravenous (IV) medicines and have an ejection fraction (amount of blood pumped with each heartbeat) of less than 45 percent to reduce the risk of dying and to reduce the need to be hospitalized.
VERQUVO may cause birth defects if taken during pregnancy.
- Females must not be pregnant when they start taking VERQUVO.
- For females who are able to get pregnant:
- Your healthcare provider will do a pregnancy test to make sure that you are not pregnant before you start taking VERQUVO.
- You must use effective forms of birth control during treatment and for 1 month after you stop treatment with VERQUVO. Talk to your healthcare provider about forms of birth control that you may use to prevent pregnancy during treatment.
- Tell your healthcare provider right away if you become pregnant or think you are pregnant during treatment with VERQUVO.
- There is a Pregnancy Surveillance Program that monitors pregnancy outcomes in women exposed to VERQUVO during pregnancy. Patients should report any exposure to VERQUVO during pregnancy by calling 1-877-888-4231or at https://pregnancyreporting.verquvo-us.com.
Do not take VERQUVO if you:
- are taking another medicine called a soluble guanylate cyclase stimulator (sGC). Ask your healthcare provider if you are not sure if you are taking an sGC medicine.
- are pregnant.
Before taking VERQUVO, tell your healthcare provider about all your medical conditions, including if you:
- are breastfeeding or plan to breastfeed. It is not known if VERQUVO passes into your breast milk. Do not breastfeed if you take VERQUVO. Talk with your healthcare provider about the best way to feed your baby if you take VERQUVO.
Tell your healthcare provider about all the medicines you take. Certain other medicines may affect how VERQUVO works.
The most common side effects of VERQUVO include:
- low blood pressure
- low red blood cells (anemia)
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please read the accompanying Medication Guide for VERQUVO, including the information about birth defects if taken during pregnancy, and discuss it with your doctor. The physician Prescribing Information also is available.